Search
for

    Sort by

    Research 151–180 of 1000+

    1. Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate Urology · 1998 · 52 citations
    2. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase Scientific Reports · 2016 · 43 citations
    3. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 41 citations
    4. Finasteride-its impact on sexual function and prostate cancer Journal of Cutaneous and Aesthetic Surgery · 2009 · 33 citations
    5. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    6. Ganoderma lucidum is an inhibitor of testosterone-induced prostatic hyperplasia in rats Andrologia · 2011 · 24 citations
    7. Finasteride: The First 5α-Reductase Inhibitor Pharmacotherapy · 1993 · 23 citations
    8. Corn silk extract improves benign prostatic hyperplasia in experimental rat model Nutrition Research and Practice · 2017 · 20 citations
    9. Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis PLOS ONE · 2018 · 19 citations
    10. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians Asian journal of urology · 2017 · 19 citations
    11. Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia Pharmaceutical biology · 2019 · 16 citations
    12. Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients European Urology Supplements · 2003 · 12 citations
    13. Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer Journal of The European Academy of Dermatology and Venereology · 2014 · 11 citations
    14. Economic Issues in the Treatment of BPH European Urology Supplements · 2006 · 11 citations
    15. Alcohol and Prostate Cancer: Time to Draw Conclusions Biomolecules · 2022 · 9 citations
    16. Abiraterone and spironolactone in prostate cancer: a combination to avoid Acta Clinica Belgica · 2018 · 9 citations
    17. Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats Research and reports in urology · 2022 · 6 citations
    18. Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention Journal of Clinical Oncology · 2009 · 6 citations
    19. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    20. Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats 2015 · 5 citations
    21. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    22. What are the possible reasons for urethral PSA varieties after radical prostatectomy? Acta Chirurgica Iugoslavica · 2010 · 5 citations
    23. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    24. Hormonal treatment for male-pattern hair loss: implications for cancer of the prostate? BJUI · 2002 · 4 citations
    25. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 3 citations
    26. Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies Scientific Reports · 2025 · 1 citations
    27. Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology · 2024 · 1 citations
    28. Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines European Journal of Pharmacology · 2022 · 1 citations
    29. Finasteride in Androgenic Alopecia Journal of the Dermatology Nurses’ Association · 2016 · 1 citations
    30. 복분자 미숙과 추출물이 전립선암 세포주와 전립선비대 백서모델에 미치는 영향 Journal of the Korean Society of Food Science and Nutrition · 2014 · 1 citations